IgA interaction with carboxy-terminal 43-kD fragment of fibronectin in IgA nephropathy

Journal of the American Society of Nephrology

Volumn 10, Issue 2, 1999, Pages 256-263

  Waga, Shinobu ^a   Sugimoto, Kazuhiko ^a   Tanaka, Hiroshi ^a   Ito, Tatsuo ^a   Nakahata, Tohru ^a   Tateyama, Takashi ^a   Kakizaki, Yoshiki ^a   Yokoyama, Masaru ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; IMMUNOGLOBULIN A;

ANTIBODY AFFINITY; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; IMMUNOPATHOGENESIS; PRIORITY JOURNAL;

EID: 0032904380     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Chauveau D, Droz D: Follow-up evaluation of the first patients with IgA nephropathy described at Necker Hospital. Contrib Nephrol 104: 1-5, 1993
2. Berger J, Yaneva H, Nabarra B, Barbanel C: Recurrence of mesangial deposition after renal transplantation. Kidney Int 7: 232-241, 1975
3. Conley ME, Cooper MD, Michael AF: Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura neophytes and systemic lupus erythematosus. J Clin Invest 66: 1432-1436, 1980
4. Emancipator SN, Gallo GR, Lamm ME: IgA nephropathy: Perspectives on pathogenesis and classification. Clin Nephrol 34: 161-179, 1985
5. Cederholm B, Wieslander J, Bygren P, Heinegard D: Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy. Proc Natl Acad Sci USA 85: 4865-4868, 1988
6. Van den Dobbelsteen MEA, Van der Woude FJ, Schroeijers WEM, Van den Wall Bake AWL, Van Es LA, Daha MR: Binding of dimeric and polymeric IgA to rat renal mesangial cells enhances the release of interleukin 6. Kidney Int 46: 512-519, 1994
7. Gómez-Guerrero C, Lopéz-Armada MJ, Gonzalez E, Egido J: Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-α and IL-6, and proliferation. J Immunol 153: 5247-5255, 1994
8. Hiki Y, Iwase H, Kokubo T, Horii A, Tanaka A, Nishikido J, Hotta K, Kobayashi Y: Association of asialo-galactosyl β1-3N-acetylgalactosamine on the hinge with a conformational instability of jacalin-reactive immunoglobulin A1 in immunoglobulin A nephropathy. J Am Soc Nephrol 1: 955-960, 1996
9. Jennette JC, Wieslander J, Tuttle R, Falk RJ, for the Glomerular Disease Collaborative Network: Serum IgA-fibronectin aggregates in patients with IgA nephropathy and Henoch-Schönlein purpura: Diagnostic value and pathogenic implications. Am J Kidney Dis 18: 466-471, 1991
10. Davin JC, Vecchi ML, Nagy J, Foidart JM, Foidart JB, Sangiorgi GB, Malaise M, Mahieu P: Evidence that the interaction between circulating IgA and fibronectin is a normal process enhanced in primary IgA nephropathy. J Clin Immunol 11: 78-94, 1991
11. Eitner F, Schulze M, Brunkhorst R, Koch KM, Floege J: On the specificity of assays to detect circulating immunoglobulin A-fibronectin complexes: Implications for the study of serologic phenomena in patients with immunoglobulin A nephropathy. J Am Soc Nephrol 5: 1400-1406, 1994
12. Cederholm B, Persson B, Swedenborg P: IgA-fibronectin complexes in serum and plasma samples. In: Pathogenesis of IgA Nephropathy, edited by Sakai H, Sakai O, Nomoto Y, Tokyo, Harcourt Brace Javanovich Japan, 1990, pp 151-160
13. Rostagno AA, Frangione B, Gold L: Biochemical studies on the interaction of fibronectin with Ig. J Immunol 146: 2687-2693, 1991
14. Czop JK, Kadish JL, Zepf DM, Austen KF: Characterization of opsonic and monocyte adherence functions of the specific fibronectin fragment that enhances phagocytosis of paniculate activators. J Immunol 134: 1844-1850, 1985
15. Carsons S, Lavietes BB, Diamond HS, Kinney SG: The immunoreactivity, ligand, and cell binding characteristics of rheumatoid synovial fluid fibronectin. Arthritis Rheum 28: 601-612, 1985
16. Scottie J, Wiley S: Assembly of amino-terminal fibronectin dimers into the extracellular matrix. J Biol Chem 269: 17492-17498, 1994
17. Rosenblum ND: The mesangial matrix in the normal and sclerotic glomerulus. Kidney Int 45[Suppl 45]: S73-S77, 1994
18. Mazanec MB, Nedrud JG, Liang XP, Lamm ME: Transport of serum IgA into murine respiratory secretions and its implications for immunization strategies. J Immunol 142: 4275-4281, 1989
19. Waga S, Tan EM, Rubin RL: Identification and isolation of soluble histones from bovine milk. Biochem J 244: 675-682, 1987
20. Hayashi M, Yamada KM: Divalent cation modulation of fibronectin binding to heparin and to DNA. J Biol Chem 257: 5263-5267, 1982
21. Loomes LM, Stewart WW, Mazengera RL, Senior BW. Kerr MA: Purification and characterization of human immunoglobulin IgA1 and IgA2 isotypes from serum. J Immunol Methods 141: 209-218, 1991
22. Katayama M, Hino F, Odate Y, Goto Y, Kimizuka F, Kato I, Titani K, Sekiguchi K: Isolation and characterization of two monoclonal antibodies that recognize remote epitopes on the cell-binding domain of human fibronectin. Exp Cell Res 185: 229-236, 1989
23. Roque-Barreira MC, Campos-Neto A: Jacalin: An IgA-binding lectin. J Immunol 134: 1740-1743, 1985
24. Smith DE, Furcht LT: Localization of two unique heparin binding domains of human plasma fibronectin with monoclonal antibodies. J Biol Chem 257: 6518-6523, 1982
25. Toschi V, Fiorini GF, Motta A, Castelli C, Gagliano MG, Gibelli A: Structural and functional characterization of plasma fibronectin in patients with essential mixed cryoglobulinaemia. Eur J Clin Chem Clin Biochem 30: 473-479, 1992
26. Vuento M, Vaheri A: Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. Biochem J 183: 331-337, 1979
27. Mohi H, Tanabe J, Katoh K, Okubo T: Identification of a novel binding site to the integrin alphaIIbβ3 located in the C-terminal heparin-binding domain of human plasma fibronectin. J Biol Chem 271: 15724-15728, 1996
28. Homandberg GA, Kramer-Bjerke J, Grant D, Chistianson G, Eisenstein R: Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth: Structure-function correlations. Biochim Biophys Acta 874: 61-71, 1986
29. Morla A, Zhang A, Ruoslahti E: Superfibronectin is a functionally distinct form of fibronectin. Nature 367: 193-196, 1994
30. Waga S, Sugimoto K, Ito T, Yokoyama M: Carboxyl-terminal fragment of fibronectin found in IgA nephropathy binds IgA1 and IgG to extracellular matrix. J Am Soc Nephrol 8: 546A, 1997